MedTrace Logo

Dexmedetomidine Pharmacokinetics During Continuous Renal Replacement Therapy (CRRT)

NCT01314209 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2012-10-24

No results posted yet for this study

Summary

The purpose of this study is to determine dexmedetomidine pharmacokinetics during continuous renal replacement therapy on critically ill patients.

Conditions

Interventions

DRUG

Dexmedetomidine

Dexmedetomidine 0.7 microg/kg/h 12-hour intravenous infusion

Sponsors & Collaborators

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Kirsi-Maija Kaukonen, MD, PhD · Division of Anaesthesia and Intensive Care Medicine, Department of Surgery, HUCH

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2014-03-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01314209 on ClinicalTrials.gov